Dr. McCann on Combination Trials With PARP Inhibitors in Ovarian Cancer
May 30th 2018Kelly McCann, MD, PhD, a medical oncologist in the Breast Cancer Research Group at the University of California, Los Angeles, discusses combination clinical trials of PARP inhibitors in patients with ovarian cancer.
Read More